SynPhNe Secures Funding to Expand Revolutionary Brain-Muscle Training Technology Worldwide

We are thrilled to announce that SynPhNe has successfully raised $5 million in its latest funding round, aimed at advancing our mission of transforming therapy delivery for individuals facing physical, cognitive, and emotional challenges. As the world's first connected wearable solution that trains both brain and muscle simultaneously, our innovative technology utilizes real-time, synchronized EEG and EMG signals to create a self-correcting learning loop. This unique capability allows users to self-administer physical therapy, occupational therapy, and neurotherapy protocols in the comfort of their homes after initial training with a therapist. This latest infusion of capital will bolster our efforts to expand our market presence and enhance product development for our two main platforms: the SynPhNe™ Xpert, designed for healthcare providers, and the SynPhNe™ eNabl, catering to home users. Both products have received FDA Class I and HSA Class A certifications, ensuring compliance with the highest safety standards. With established training centers in Singapore and Mumbai, along with strategic partnerships with reputable hospitals and physiotherapy centers, the funding will allow us to further penetrate international markets and scale pilot projects in the United States. Ultimately, we believe this investment will help us better serve individuals affected by neurological disabilities, learning disorders, and age-related challenges, providing them with greater access to effective, at-home therapeutic solutions. We are excited about the potential impact this funding will have on the lives of countless individuals around the globe.